Sbi Securities Co., Ltd. Inmune Bio, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 1,671 shares of INMB stock, worth $16,726. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,671Holding current value
$16,726% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INMB
# of Institutions
72Shares Held
6.01MCall Options Held
243KPut Options Held
46.4K-
Black Rock Inc. New York, NY813KShares$8.14 Million0.0% of portfolio
-
Praetorian Pr LLC Rincon, PR781KShares$7.82 Million1.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA721KShares$7.21 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$5.97 Million45.87% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL476KShares$4.76 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $180M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...